A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.
In the last few years it has been shown that the humoral immune response in cancer patients is a rich source of putative cancer vaccine candidates. To fully explore the complex information present within the Ab repertoire of cancer patients, we have applied a method, serological Ag selection, to molecularly define tumor Ags recognized by the humoral immune response in colorectal cancer (CRC). First, we built a cDNA display library by cloning a cDNA library from CRC cell line HT-29 for expression as a fusion protein with a filamentous phage minor coat protein, pVI. This cDNA display library was then enriched on pooled sera from CRC patients who had undergone active specific immunization with autologous tumor. We identified a panel of 19 clones reactive with the serum pool. Seventeen of 19 (89%) clones showed reactivity with one or more of the eight Ag-reactive sera, conversely six of eight (75%) sera were reactive with at least one of the 19 clones. Sequencing revealed that these 19 clones represented 13 different Ags. A detailed serological analysis of the 13 different Ags showed preferential reactivity to sera of cancer patients for six different Ags. Four of these Ags displayed increased serum reactivity after the active specific immunization procedure. Furthermore, one of the six Ags, a novel Ag homologous to HSPC218, showed restricted expression in normal testis, suggesting that it belongs to the cancer-testis Ag family. Some of the Ags we have identified may be candidates for tumor vaccination, for sero-diagnosis of cancer, as prognostic markers, or as probes for monitoring tumor cell-based vaccination trials.
Dyax s.a., Liege, Belgium.
Veerle A
VA
Somers
Ricardo J
RJ
Brandwijk
Ben
B
Joosten
Peter T
PT
Moerkerk
Jan-Willem
JW
Arends
Paul
P
Menheere
Wendy O
WO
Pieterse
Anke
A
Claessen
Rik J
RJ
Scheper
Hennie R
HR
Hoogenboom
Simon E
SE
Hufton
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000912:Antibodies, Neoplasm / Q000097:blood; D000937:Antigen-Antibody Reactions / Q000235:genetics; D000951:Antigens, Neoplasm / Q000096:biosynthesis / Q000097:blood / Q000235:genetics* / Q000302:isolation & purification*; D003001:Cloning, Molecular / Q000379:methods; D015179:Colorectal Neoplasms / Q000097:blood / Q000276:immunology*; D018076:DNA, Complementary / Q000096:biosynthesis*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D015723:Gene Library; D019073:HT29 Cells; D006801:Humans; D017912:Inovirus / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis / Q000235:genetics; D020539:Sequence Analysis, Protein
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D018076:DNA, Complementary; D010446:Peptide Fragments